← Browse by Condition
Medical Condition

refractory acute leukemia of ambiguous lineage

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04375631 Phase 1
Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Enrollment
120 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
View Trial →